logo

OTLK

Outlook Therapeutics·NASDAQ
--
--(--)
--
--(--)

OTLK fundamentals

Outlook Therapeutics (OTLK) released its earnings on Dec 19, 2025: revenue was -100.00K (YoY 0.00%), missed estimates; EPS was -0.06 (YoY +93.18%), beat estimates.
Revenue / YoY
-100.00K
0.00%
EPS / YoY
-0.06
+93.18%
Report date
Dec 19, 2025
EPS
Revenue

Revenue & Expenses

OTLK has released its 2025 Q4 earnings report, with revenue of -91.79K, reflecting a YoY change of NaN%, and net profit of -13.29M, showing a YoY change of -333.56%. The Sankey diagram below clearly presents OTLK's revenue sources and cost distribution.

Key Indicators

Outlook Therapeutics (OTLK) key financial stats and ratios, covering profitability, financial health, and leverage.
Outlook Therapeutics (OTLK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Outlook Therapeutics (OTLK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Outlook Therapeutics (OTLK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Outlook Therapeutics (OTLK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Outlook Therapeutics (OTLK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield